COALITION LETTER
Antitrust Bills’ Harm

Shifting the focus of antitrust law away from helping consumers and toward bolstering competitors would hinder economic growth and undermine decades of antitrust precedent. Moreover, they offer no solution to broader concerns about technology and privacy.

COALITION LETTER
Opposition to S. 2992

Sen. Amy Klobuchar’s antitrust bill, the American Innovation and Choice Online Act, gives the Biden administration vast new regulatory authority over American businesses, fails to address conservative censorship concerns and would make inflation worse for American families.

STATEMENT
Senate PDUFA Should Drop Dangerous Drug Importation

Drug importation is inherently high-risk.  No HHS secretary, Republican or Democratic, from 1987 until 2020 dared to deem importation as safe for patients or significantly cost-saving for U.S. consumers.  Nothing’s changed.  Drug importation risks harm from adulterated or counterfeit pharmaceuticals.

STATEMENT
Senate and House Hearings on PTAB

PTAB endangers America’s inventors whose commercial success is vital to our global leadership in innovation. Beleaguered inventors face tremendous threats, due to PTAB and its most frequent users, Big Tech and Chinese national champions.

AMICUS BRIEF
Palo Alto Networks v. Centripetal Networks

CPR strongly supports Centripetal Networks’s request for rehearing and POP review of the decision instituting IPR. Centripetal won in Article III court. Palo Alto is gaming the system to get leverage in separate litigation involving different patents.

STATEMENT
CPR Applauds RSC’s FY23 Budget

The Republican Study Committee FY 2023 budget would repair America’s fiscal foundation and empower people. It’s a brilliant blueprint for addressing America’s urgent problems.

COALITION LETTER
80 Conservatives Oppose 95% Rx Tax

In a time of inflation levels not seen in decades, the last thing Americans need is a 95% tax that would nearly double the price of the prescription medicines they need to live healthy and fulfilling lives. A price control to avoid the tax isn’t a better option.

COALITION LETTER
ATR-Led Oppo to TRIPS Waiver on American Innovation

Waiving TRIPS would allow foreign countries to immediately seize patents and clinical data of American businesses in order to attempt to produce COVID-19 vaccines. This would give foreign countries access to sensitive, valuable proprietary information belonging to American businesses.

AMICUS BRIEF
CPR Joins Amicus Brief in Sackett v. EPA

Amici urge the Supreme Court to adopt a "continuous surface connection" standard in WOTUS wetlands cases under the Clean Water Act. This will reduce regulatory takings and Fifth Amendment violations.

LETTER
CPR Support for S. 3772 to Stop Chinese Courts

The Defending American Courts Act ensures that intellectual property owners have access to U.S. courts and can exercise their American IP rights.  S. 3772 would constrain the use of a disturbing, growing practice of certain foreign courts, particularly in China.

COALITION LETTER
Opposition to Misuse of Bayh-Dole March-In

Some 31 signers from 29 center-right groups urge HHS to ignore calls and petitions asking HHS to deliberately twist the plain meaning of the bipartisan Bayh-Dole Act in ways that would decimate technological and medical progress.

LETTER
Comments on Draft SEP Policy Statement

DOJ's draft statement on standards-essential patents falls short of achieving the proper balance, neutrality, and respect for both innovators and implementers in their complementary roles related to innovation, SEPs, and licensing. 

LETTER
Budget Reconciliation & Inflation

H.R. 5376 will worsen the hidden "tax" of inflation, already reaching the highest level in 30 years.  Inflationary pressures will stem from the climate provisions, adverse effects on our mature domestic energy industry, government price controls that will stifle U.S. innovation and competitiveness, and massive new government spending.

COALITION LETTER
Budget Reconciliation Drug Price Controls

Center-right groups wrote Congress expressing opposition to drug price controls from the radical H.R. 3 contained in H.R. 5376. The partisan budget package's price controls will harm patients and reduce innovation.

COALITION LETTER
Opposition to Budget Reconciliation Tax Schemes

CPR joined 112 family business advocates urging congressional tax writers not to tax "phantom [capital] gains in any form, whether through unrealized gains at death or through the recently released mark-to-market approach."

LETTER
The Restoring America's Leadership in Innovation Act

H.R. 5874, the Restoring America’s Leadership in Innovation Act, would strengthen private property rights in one’s inventions and discoveries. The bill would go a long way toward reversing the antipatent onslaught of recent years. RALIA would counter the sustained assault by courts, Congress, the Administrative State, and patent-infringer interests.

LETTER
Opposition to Estate Tax Hikes in Budget Reconciliation

CPR wrote Ways & Means to express strong opposition to any Death Tax or "double death tax" measures, including changing capital gains treatment at death, in House budget reconciliation package.

STATEMENT
Support for RSC's Countering Communist China Act

The Republican Study Committee has crafted effective legislation in the Countering Communist China Act. Its comprehensive approach reflects the fact that America’s industrial competitiveness is at stake when adversaries can freely break the rules, conduct espionage and plunder American private property — especially patents and other IP.

VIDEO

CPR Briefing on Property Rights

This webinar, hosted by Conservatives for Property Rights, highlights how ownership rights relate to private property of every type. Keynote Speaker: Rep. Dan Newhouse (R-Wash.), House Chairman, Congressional Western Caucus.